Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
GEO DataSets Profile neighbors
FNBP1 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MED14 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
MSI2 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
SLC35E1 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
N4BP1 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
MIR3682 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC7A5 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
CCDC93 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
PWWP2B - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
ARID4B - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
TAPT1 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
REL - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
TNFSF14 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
PBX4 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
RALGAPA1 - Treatment-naive, chronic hepatitis C virus-infected patients: CD4+ and CD8+ T-lymphocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on